The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Perospirone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with carisoprodol.


The risk or severity of adverse effects can be increased when diazepam is combined with pimozide.


The risk or severity of adverse effects can be increased when difluprednate is combined with tubocurarine.


The risk or severity of adverse effects can be increased when doxazosin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with tizanidine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Risedronic acid is combined with atorvastatin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when thiopental is combined with scopolamine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with isoetharine.


The risk or severity of adverse effects can be increased when gabapentin is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with minoxidil.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Metixene.


The risk or severity of adverse effects can be increased when Telaprevir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Halobetasol.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when meperidine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when buspirone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when imipramine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when clorazepate is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Telmisartan is combined with penbutolol.


The risk or severity of adverse effects can be increased when alprazolam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when morphine is combined with baclofen.


The risk or severity of adverse effects can be increased when Rufinamide is combined with dyclonine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with doxepin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when morphine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when gabapentin is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when nisoldipine is combined with fosinopril.


The risk or severity of adverse effects can be increased when Masoprocol is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when levorphanol is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when HEROIN is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Spirapril is combined with tolmetin.


The risk or severity of adverse effects can be increased when Lofexidine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when morphine is combined with prazepam.


The risk or severity of adverse effects can be increased when HEROIN is combined with MELPERONE.


The risk or severity of adverse effects can be increased when HEROIN is combined with zotepine.


The risk or severity of adverse effects can be increased when morphine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when morphine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when levorphanol is combined with flunarizine.


The risk or severity of adverse effects can be increased when ethanol is combined with methylene blue.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when butenafine is combined with flunarizine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with DALFOPRISTIN.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with metoclopramide.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with flunarizine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when quazepam is combined with thiopental.


The risk or severity of adverse effects can be increased when desoximetasone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when oxazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Naftifine.


The risk or severity of adverse effects can be increased when desoximetasone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when gabapentin is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Perospirone is combined with clidinium.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with moclobemide.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Clobetasone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with butamben.


The risk or severity of adverse effects can be increased when Vilazodone is combined with periciazine.


The risk or severity of adverse effects can be increased when Tianeptine is combined with terbutaline.


The risk or severity of adverse effects can be increased when loxapine is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when irbesartan is combined with Apremilast.


The risk or severity of adverse effects can be increased when linezolid is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when clonidine is combined with doxazosin.


The risk or severity of adverse effects can be increased when amifostine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when nimodipine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when alclometasone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Tolcapone.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with amitriptyline.


The risk or severity of adverse effects can be increased when gabapentin is combined with paroxetine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Propiverine.


The risk or severity of adverse effects can be increased when temazepam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when efavirenz is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when thiopental is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Perospirone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Perospirone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Talniflumate is combined with mesalamine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Olopatadine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Alvimopan.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with fenoprofen.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Milnacipran.


The risk or severity of adverse effects can be increased when docetaxel is combined with Bortezomib.


The risk or severity of adverse effects can be increased when butorphanol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when lisinopril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with tolterodine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when lisinopril is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when furosemide is combined with ouabain.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Icatibant.


The risk or severity of adverse effects can be increased when tolmetin is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Mersalyl.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with quetiapine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with betaxolol.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with ibudilast.


The risk or severity of adverse effects can be increased when fenoprofen is combined with epirizole.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with prazosin.


The risk or severity of adverse effects can be increased when Perospirone is combined with doxepin.


The risk or severity of adverse effects can be increased when Asenapine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Asenapine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when nefazodone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with perphenazine.


The risk or severity of adverse effects can be increased when estrone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with bromocriptine.


The risk or severity of adverse effects can be increased when risperidone is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Linagliptin is combined with benazepril.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when simvastatin is combined with DAPTOMYCIN.


The risk or severity of adverse effects can be increased when butorphanol is combined with oxymorphone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Clofarabine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when budesonide is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when epinephrine is combined with dobutamine.


The risk or severity of adverse effects can be increased when carprofen is combined with diflorasone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Cariprazine.


The risk or severity of adverse effects can be increased when triamterene is combined with terazosin.


The risk or severity of adverse effects can be increased when tetracaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when betamethasone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with decamethonium.


The risk or severity of adverse effects can be increased when resveratrol is combined with salicylic acid.


The risk or severity of adverse effects can be increased when imipramine is combined with promethazine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when imipramine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when imipramine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with budesonide.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with brotizolam.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when clonidine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when clomipramine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when tetracaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with oxybutynin.


The risk or severity of adverse effects can be increased when proparacaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when reserpine is combined with methyldopa.


The risk or severity of adverse effects can be increased when sevoflurane is combined with nitrazepam.


The risk or severity of adverse effects can be increased when clonidine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when reserpine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with sertraline.


The risk or severity of adverse effects can be increased when reserpine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when reserpine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when reserpine is combined with zaleplon.


The risk or severity of adverse effects can be increased when chlormezanone is combined with clomipramine.


The risk or severity of adverse effects can be increased when cilazapril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when resveratrol is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when paroxetine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with topiramate.


The risk or severity of adverse effects can be increased when methenamine is combined with sulpiride.


The risk or severity of adverse effects can be increased when lorazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with estrone.


The risk or severity of adverse effects can be increased when olanzapine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when moclobemide is combined with Lurasidone.


The risk or severity of adverse effects can be increased when mesalamine is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with clomipramine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with difluprednate.


The risk or severity of adverse effects can be increased when Olsalazine is combined with halcinonide.


The risk or severity of adverse effects can be increased when ATOVAQUONE is combined with dapsone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with amoxapine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with triamterene.


The risk or severity of adverse effects can be increased when secobarbital is combined with meclizine.


The risk or severity of adverse effects can be increased when clonidine is combined with bumetanide.


The risk or severity of adverse effects can be increased when butorphanol is combined with butalbital.


The risk or severity of adverse effects can be increased when Naftifine is combined with salicylic acid.


The risk or severity of adverse effects can be increased when salicylamide is combined with Mometasone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Torasemide.


The risk or severity of adverse effects can be increased when pimozide is combined with MELPERONE.


The risk or severity of adverse effects can be increased when pimozide is combined with zotepine.


The risk or severity of adverse effects can be increased when olanzapine is combined with phenobarbital.


The risk or severity of adverse effects can be increased when Naftifine is combined with aspirin.


The risk or severity of adverse effects can be increased when clofazimine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Aclidinium is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when butorphanol is combined with Lurasidone.


The risk or severity of adverse effects can be increased when minoxidil is combined with terazosin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with nelfinavir.


The risk or severity of adverse effects can be increased when PROCATEROL is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when methylergonovine is combined with indinavir.


The risk or severity of adverse effects can be increased when haloprogin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when cocaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when rasagiline is combined with Cariprazine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with fenbufen.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Cariprazine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when methadone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when codeine is combined with potassium ion.


The risk or severity of adverse effects can be increased when Naftifine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when quinidine is combined with pentazocine.


The risk or severity of adverse effects can be increased when dobutamine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with flumethasone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with clidinium.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with metolazone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with buspirone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with chlormezanone.


The risk or severity of adverse effects can be increased when thioridazine is combined with hydralazine.


The risk or severity of adverse effects can be increased when thiothixene is combined with tiapride.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Apixaban.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with PAMABROM.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when thalidomide is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when lorazepam is combined with Etomidate.


The risk or severity of adverse effects can be increased when lorazepam is combined with morphine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Asenapine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with azelastine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Caspofungin is combined with cinnarizine.


The risk or severity of adverse effects can be increased when prazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with butalbital.


The risk or severity of adverse effects can be increased when Masoprocol is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when oxymorphone is combined with levodopa.


The risk or severity of adverse effects can be increased when oxymorphone is combined with sevoflurane.


The risk or severity of adverse effects can be increased when moclobemide is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Droxicam.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when sotalol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when fosinopril is combined with Salsalate.


The risk or severity of adverse effects can be increased when cinnarizine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Conivaptan is combined with terazosin.


The risk or severity of adverse effects can be increased when secobarbital is combined with glutethimide.


The risk or severity of adverse effects can be increased when secobarbital is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when lidocaine is combined with loratadine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with lithium ion.


The risk or severity of adverse effects can be increased when aspirin is combined with diflorasone.


The risk or severity of adverse effects can be increased when Asenapine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Asenapine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when sulindac is combined with epirizole.


The risk or severity of adverse effects can be increased when flurazepam is combined with propofol.


The risk or severity of adverse effects can be increased when procarbazine is combined with mianserin.


The risk or severity of adverse effects can be increased when quinapril is combined with fenbufen.


The risk or severity of adverse effects can be increased when prilocaine is combined with clonidine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Halazepam is combined with nefazodone.


The risk or severity of adverse effects can be increased when sulindac is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when floctafenine is combined with salicylic acid.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with medrysone.


The risk or severity of adverse effects can be increased when amiodarone is combined with dipyridamole.


The risk or severity of adverse effects can be increased when benztropine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Halazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when floctafenine is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when sulindac is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when zaleplon is combined with proparacaine.


The risk or severity of adverse effects can be increased when nicardipine is combined with papaverine.


The risk or severity of adverse effects can be increased when nicardipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Halazepam.


The risk or severity of adverse effects can be increased when thiamylal is combined with Pizotifen.


The risk or severity of adverse effects can be increased when quinapril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when clomipramine is combined with penbutolol.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when nitrazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Metipranolol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with estazolam.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with dantrolene.


The risk or severity of adverse effects can be increased when ketamine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when desoximetasone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when ketamine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when felbamate is combined with dantrolene.


The risk or severity of adverse effects can be increased when prilocaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when propantheline is combined with mecamylamine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with amcinonide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with chlormezanone.


The risk or severity of adverse effects can be increased when propantheline is combined with pentazocine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ibuprofen is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Escitalopram.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when cilazapril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when sevoflurane is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when cilazapril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when fenbufen is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when halothane is combined with Articaine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with zonisamide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with desipramine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with thiamylal.


The risk or severity of adverse effects can be increased when bromocriptine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with glyburide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with halothane.


The risk or severity of adverse effects can be increased when bromocriptine is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when triazolam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when triazolam is combined with lithium ion.


The risk or severity of adverse effects can be increased when bromocriptine is combined with metyrapone.


The risk or severity of adverse effects can be increased when quinapril is combined with terazosin.


The risk or severity of adverse effects can be increased when papaverine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Rifampicin is combined with clopidogrel.


The risk or severity of adverse effects can be increased when levorphanol is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with alprazolam.


The risk or severity of adverse effects can be increased when bepridil is combined with tizanidine.


The risk or severity of adverse effects can be increased when pancuronium is combined with codeine.


The risk or severity of adverse effects can be increased when bepridil is combined with furosemide.


The risk or severity of adverse effects can be increased when nicergoline is combined with atorvastatin.


The risk or severity of adverse effects can be increased when amisulpride is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when meclizine is combined with Retigabine.


The risk or severity of adverse effects can be increased when metolazone is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with loxapine.


The risk or severity of adverse effects can be increased when Telaprevir is combined with bepridil.


The risk or severity of adverse effects can be increased when meprobamate is combined with nitrazepam.


The risk or severity of adverse effects can be increased when dyclonine is combined with baclofen.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with levodopa.


The risk or severity of adverse effects can be increased when propoxyphene is combined with polythiazide.


The risk or severity of adverse effects can be increased when dibucaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when dibucaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when propoxyphene is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when metolazone is combined with quetiapine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when labetalol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Prasugrel is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with sulindac.


The risk or severity of adverse effects can be increased when nitric oxide is combined with tolazoline.


The risk or severity of adverse effects can be increased when ropinirole is combined with selegiline.


The risk or severity of adverse effects can be increased when ethanol is combined with metformin.


The risk or severity of adverse effects can be increased when phentolamine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with chloroquine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with enoxacin.


The risk or severity of adverse effects can be increased when etodolac is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when alclofenac is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Eprosartan.


The risk or severity of adverse effects can be increased when lidocaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when selegiline is combined with amisulpride.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Tapentadol.


The risk or severity of adverse effects can be increased when alclofenac is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when flurazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when flurazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Dothiepin.


The risk or severity of adverse effects can be increased when glutethimide is combined with felbamate.


The risk or severity of adverse effects can be increased when estazolam is combined with doxepin.


The risk or severity of adverse effects can be increased when benzocaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with estrone.


The risk or severity of adverse effects can be increased when benzocaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when benzocaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when clidinium is combined with felbamate.


The risk or severity of adverse effects can be increased when dyclonine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when dyclonine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when phentolamine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with HEROIN.


The risk or severity of adverse effects can be increased when cocaine is combined with topiramate.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with resveratrol.


The risk or severity of adverse effects can be increased when minoxidil is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Propacetamol is combined with desoximetasone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with maprotiline.


The risk or severity of adverse effects can be increased when Milnacipran is combined with warfarin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with loratadine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with loratadine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Torasemide.


The risk or severity of adverse effects can be increased when venlafaxine is combined with rasagiline.


The risk or severity of adverse effects can be increased when nalbuphine is combined with imipramine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with imipramine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with tetracaine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with prednisone.


The risk or severity of adverse effects can be increased when dobutamine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when tropicamide is combined with quinidine.


The risk or severity of adverse effects can be increased when quazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when halothane is combined with Escitalopram.


The risk or severity of adverse effects can be increased when halothane is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with doxazosin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Butethal is combined with fludiazepam.


The risk or severity of adverse effects can be increased when apomorphine is combined with terazosin.


The risk or severity of adverse effects can be increased when Butethal is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when prilocaine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Normethadone is combined with indapamide.


The risk or severity of adverse effects can be increased when brotizolam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when brotizolam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with decamethonium.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when sotalol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when amoxapine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when promazine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when salicylic acid is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when benztropine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when buspirone is combined with tizanidine.


The risk or severity of adverse effects can be increased when ketoconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when midazolam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Apremilast.


The risk or severity of adverse effects can be increased when enflurane is combined with Perospirone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with tolazoline.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when procarbazine is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when indapamide is combined with bumetanide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Caspofungin is combined with nifedipine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with nimesulide.


The risk or severity of adverse effects can be increased when indapamide is combined with quinapril.


The risk or severity of adverse effects can be increased when Masoprocol is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with trimipramine.


The risk or severity of adverse effects can be increased when Salsalate is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when pimozide is combined with estazolam.


The risk or severity of adverse effects can be increased when apomorphine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when CAPECITABINE is combined with clozapine.


The risk or severity of adverse effects can be increased when doxepin is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when antipyrine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when pimozide is combined with dantrolene.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with polythiazide.


The risk or severity of adverse effects can be increased when Eplerenone is combined with bumetanide.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Olopatadine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when nitrazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when cetirizine is combined with dantrolene.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with doxepin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with bumetanide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when amobarbital is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with dantrolene.


The risk or severity of adverse effects can be increased when MELPERONE is combined with primidone.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when dibucaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when nalbuphine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when diflorasone is combined with edrophonium.


The risk or severity of adverse effects can be increased when meperidine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with baclofen.


The risk or severity of adverse effects can be increased when methylene blue is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when Rufinamide is combined with loxapine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Remoxipride.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with alprazolam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Olopatadine.


The risk or severity of adverse effects can be increased when dibucaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when quetiapine is combined with HEROIN.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with efavirenz.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with lithium ion.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when bromazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when perphenazine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when clorazepate is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when HEROIN is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with clomipramine.


The risk or severity of adverse effects can be increased when morniflumate is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with sertraline.


The risk or severity of adverse effects can be increased when Lacidipine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when nimodipine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with clidinium.


The risk or severity of adverse effects can be increased when Retigabine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when bupivacaine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when haloperidol is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when ketorolac is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when tirofiban is combined with Olsalazine.


The risk or severity of adverse effects can be increased when Trospium is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Trospium is combined with pentazocine.


The risk or severity of adverse effects can be increased when nicergoline is combined with ifosfamide.


The risk or severity of adverse effects can be increased when Tiotropium is combined with Mirabegron.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when duloxetine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with clonidine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Etomidate is combined with zonisamide.


The risk or severity of adverse effects can be increased when clozapine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with papaverine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with nifedipine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Nebivolol.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with diazoxide.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with papaverine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with nifedipine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when alclofenac is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when cabergoline is combined with selegiline.


The risk or severity of adverse effects can be increased when bromazepam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when alclofenac is combined with prednisone.


The risk or severity of adverse effects can be increased when procaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when sertraline is combined with reserpine.


The risk or severity of adverse effects can be increased when labetalol is combined with captopril.


The risk or severity of adverse effects can be increased when haloprogin is combined with diltiazem.


The risk or severity of adverse effects can be increased when zaleplon is combined with fluoxetine.


The risk or severity of adverse effects can be increased when morphine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when morphine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Milnacipran.


The risk or severity of adverse effects can be increased when diazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when morphine is combined with zaleplon.


The risk or severity of adverse effects can be increased when morphine is combined with methyldopa.


The risk or severity of adverse effects can be increased when Treprostinil is combined with mesalamine.


The risk or severity of adverse effects can be increased when pentazocine is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when methazolamide is combined with captopril.


The risk or severity of adverse effects can be increased when methazolamide is combined with acebutolol.


The risk or severity of adverse effects can be increased when halcinonide is combined with fleroxacin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with mesoridazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with thiopental.


The risk or severity of adverse effects can be increased when butamben is combined with doxepin.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Vilazodone.


The risk or severity of adverse effects can be increased when haloprogin is combined with nimodipine.


The risk or severity of adverse effects can be increased when Udenafil is combined with Avanafil.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with propofol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with MELPERONE.


The risk or severity of adverse effects can be increased when butamben is combined with nefazodone.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Droxicam is combined with betamethasone.


The risk or severity of adverse effects can be increased when butabarbital is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Palbociclib is combined with leflunomide.


The risk or severity of adverse effects can be increased when docetaxel is combined with Ruxolitinib.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when sulpiride is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when sulpiride is combined with prilocaine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with brotizolam.


The risk or severity of adverse effects can be increased when docetaxel is combined with Cabozantinib.


The risk or severity of adverse effects can be increased when sulpiride is combined with ethotoin.


The risk or severity of adverse effects can be increased when atenolol is combined with quetiapine.


The risk or severity of adverse effects can be increased when temazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with glutethimide.


The risk or severity of adverse effects can be increased when diflunisal is combined with ibuprofen.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when nimesulide is combined with Propacetamol.


The risk or severity of adverse effects can be increased when nicergoline is combined with isradipine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when docetaxel is combined with Eribulin.


The risk or severity of adverse effects can be increased when Suvorexant is combined with paroxetine.


The risk or severity of adverse effects can be increased when terazosin is combined with cilazapril.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with nifedipine.


The risk or severity of adverse effects can be increased when meperidine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Asenapine.


The risk or severity of adverse effects can be increased when quazepam is combined with trazodone.


The risk or severity of adverse effects can be increased when suprofen is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when tolmetin is combined with diflorasone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with clidinium.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with flumethasone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when methadone is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when methadone is combined with clidinium.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with meclizine.


The risk or severity of adverse effects can be increased when gabapentin is combined with trazodone.


The risk or severity of adverse effects can be increased when pergolide is combined with dexamethasone.


The risk or severity of adverse effects can be increased when levorphanol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when perphenazine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when lithium ion is combined with ethotoin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with amisulpride.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with bromazepam.


The risk or severity of adverse effects can be increased when furosemide is combined with allopurinol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when etizolam is combined with tiagabine.


The risk or severity of adverse effects can be increased when quetiapine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when codeine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with oxycodone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Fospropofol is combined with triprolidine.


The risk or severity of adverse effects can be increased when codeine is combined with meclizine.


The risk or severity of adverse effects can be increased when thiopental is combined with Desloratadine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when thiopental is combined with mepivacaine.


The risk or severity of adverse effects can be increased when tolmetin is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with oxycodone.


The risk or severity of adverse effects can be increased when tolmetin is combined with formestane.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with buspirone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Butethal.


The risk or severity of adverse effects can be increased when midazolam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with lithium ion.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when rasagiline is combined with Perospirone.


The risk or severity of adverse effects can be increased when pirenzepine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Ramelteon.


The risk or severity of adverse effects can be increased when tubocurarine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Rufinamide is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when triazolam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with oxaprozin.


The risk or severity of adverse effects can be increased when triazolam is combined with trazodone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when midazolam is combined with ethotoin.


The risk or severity of adverse effects can be increased when butorphanol is combined with tetracaine.


The risk or severity of adverse effects can be increased when halcinonide is combined with edrophonium.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with diflorasone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when methocarbamol is combined with loratadine.


The risk or severity of adverse effects can be increased when Salsalate is combined with niflumic acid.


The risk or severity of adverse effects can be increased when halothane is combined with felbamate.


The risk or severity of adverse effects can be increased when papaverine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with promethazine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with clonazepam.


The risk or severity of adverse effects can be increased when benzoic acid is combined with diltiazem.


The risk or severity of adverse effects can be increased when reserpine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when risperidone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Nepafenac is combined with flumethasone.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Aliskiren.


The risk or severity of adverse effects can be increased when oxiconazole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when triazolam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when biperiden is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when lithium ion is combined with vigabatrin.


The risk or severity of adverse effects can be increased when captopril is combined with Apremilast.


The risk or severity of adverse effects can be increased when doxazosin is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with loteprednol.


The risk or severity of adverse effects can be increased when Tolcapone is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with rasagiline.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with polythiazide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when Melatonin is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when difluprednate is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with tetracaine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Melatonin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when LISURIDE is combined with ranitidine.


The risk or severity of adverse effects can be increased when methysergide is combined with simvastatin.


The risk or severity of adverse effects can be increased when methysergide is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Phenelzine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with baclofen.


The risk or severity of adverse effects can be increased when thioridazine is combined with zonisamide.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when butabarbital is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with topiramate.


The risk or severity of adverse effects can be increased when venlafaxine is combined with periciazine.


The risk or severity of adverse effects can be increased when tetracaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when tetracaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when LISURIDE is combined with ambroxol.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with indapamide.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Naloxegol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with loratadine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with metoprolol.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with rasagiline.


The risk or severity of adverse effects can be increased when propoxyphene is combined with imipramine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when imipramine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when thiothixene is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with metolazone.


The risk or severity of adverse effects can be increased when midazolam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when ramipril is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Caspofungin.


The risk or severity of adverse effects can be increased when CALCIUM CHLORIDE is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when loteprednol is combined with edrophonium.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with mesoridazine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when prednisone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with haloperidol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when azelastine is combined with Icatibant.


The risk or severity of adverse effects can be increased when barnidipine is combined with simvastatin.


The risk or severity of adverse effects can be increased when morphine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when flurazepam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when levorphanol is combined with tetracaine.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when felodipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with loratadine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with imipramine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when morphine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when lorazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when flurazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Arotinolol is combined with clomipramine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with nifedipine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with epoprostenol.


The risk or severity of adverse effects can be increased when Arotinolol is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Arotinolol is combined with bepridil.


The risk or severity of adverse effects can be increased when Telmisartan is combined with methyldopa.


The risk or severity of adverse effects can be increased when methysergide is combined with nifedipine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with amoxapine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when methysergide is combined with miconazole.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when pirenzepine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with DESONIDE.


The risk or severity of adverse effects can be increased when oxazepam is combined with quetiapine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with isoetharine.


The risk or severity of adverse effects can be increased when betaxolol is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when oxazepam is combined with ketamine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Sunitinib.


The risk or severity of adverse effects can be increased when venlafaxine is combined with imipramine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with methazolamide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when thiothixene is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when pergolide is combined with TROLEANDOMYCIN.


The risk or severity of adverse effects can be increased when thiothixene is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Tavaborole is combined with manidipine.


The risk or severity of adverse effects can be increased when nimodipine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when budesonide is combined with physostigmine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with ILOPROST.


The risk or severity of adverse effects can be increased when budesonide is combined with rivastigmine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when difluprednate is combined with edrophonium.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when cabergoline is combined with astemizole.


The risk or severity of adverse effects can be increased when bupivacaine is combined with rasagiline.


The risk or severity of adverse effects can be increased when pentazocine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Pregabalin is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Spirapril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when amphotericin b is combined with timolol.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with haloperidol.


The risk or severity of adverse effects can be increased when Halazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when estazolam is combined with levodopa.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with sulpiride.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when antipyrine is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when clomipramine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Tolcapone.


The risk or severity of adverse effects can be increased when butamben is combined with meclizine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when morphine is combined with enflurane.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with ibuprofen.


The risk or severity of adverse effects can be increased when tiapride is combined with trimipramine.


The risk or severity of adverse effects can be increased when zotepine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when Posaconazole is combined with vincristine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with fludiazepam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when cilazapril is combined with Pregabalin.


The risk or severity of adverse effects can be increased when MELPERONE is combined with methylphenidate.


The risk or severity of adverse effects can be increased when enalapril is combined with indomethacin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with EDTA.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with dipyridamole.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with azelastine.


The risk or severity of adverse effects can be increased when quinidine is combined with Propiverine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Tramadol.


The risk or severity of adverse effects can be increased when amifostine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when zaleplon is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when meprobamate is combined with alprazolam.


The risk or severity of adverse effects can be increased when meprobamate is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when lisinopril is combined with Clevidipine.


The risk or severity of adverse effects can be increased when meprobamate is combined with loxapine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Remoxipride.


The risk or severity of adverse effects can be increased when estazolam is combined with butalbital.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when carvedilol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ILOPROST is combined with triamterene.


The risk or severity of adverse effects can be increased when zaleplon is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when protriptyline is combined with dantrolene.


The risk or severity of adverse effects can be increased when quazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Mersalyl.


The risk or severity of adverse effects can be increased when Eletriptan is combined with pimozide.


The risk or severity of adverse effects can be increased when metoclopramide is combined with mesoridazine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with irbesartan.


The risk or severity of adverse effects can be increased when Bortezomib is combined with atenolol.


The risk or severity of adverse effects can be increased when rasagiline is combined with thalidomide.


The risk or severity of adverse effects can be increased when amphotericin b is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with felodipine.


The risk or severity of adverse effects can be increased when lisinopril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when prazepam is combined with citalopram.


The risk or severity of adverse effects can be increased when nimodipine is combined with papaverine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Agomelatine.


The risk or severity of adverse effects can be increased when trapidil is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Articaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when tetracaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when oxycodone is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when oxycodone is combined with polythiazide.


The risk or severity of adverse effects can be increased when trazodone is combined with trimipramine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with triamterene.


The risk or severity of adverse effects can be increased when Pinaverium is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when pramipexole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Tiotropium is combined with HEROIN.


The risk or severity of adverse effects can be increased when hydromorphone is combined with triprolidine.


The risk or severity of adverse effects can be increased when pargyline is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when promazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Talniflumate is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when desoximetasone is combined with edrophonium.


The risk or severity of adverse effects can be increased when topiramate is combined with clonidine.


The risk or severity of adverse effects can be increased when butorphanol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with propofol.


The risk or severity of adverse effects can be increased when prednisone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when Talniflumate is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Nilotinib.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with selegiline.


The risk or severity of adverse effects can be increased when sulpiride is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Butethal is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with pimozide.


The risk or severity of adverse effects can be increased when benazepril is combined with suprofen.


The risk or severity of adverse effects can be increased when Paliperidone is combined with efavirenz.


The risk or severity of adverse effects can be increased when methocarbamol is combined with trimipramine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Imatinib.


The risk or severity of adverse effects can be increased when Masoprocol is combined with equilin.


The risk or severity of adverse effects can be increased when lisinopril is combined with acebutolol.


The risk or severity of adverse effects can be increased when SAQUINAVIR is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with Nintedanib.


The risk or severity of adverse effects can be increased when thalidomide is combined with benazepril.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with topiramate.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when azelastine is combined with halcinonide.


The risk or severity of adverse effects can be increased when bepridil is combined with Tolcapone.


The risk or severity of adverse effects can be increased when amisulpride is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when resveratrol is combined with equilin.


The risk or severity of adverse effects can be increased when Salsalate is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Tiotropium is combined with hydromorphone.


The risk or severity of adverse effects can be increased when omeprazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when ILOPROST is combined with selegiline.


The risk or severity of adverse effects can be increased when enalapril is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Glubionate calcium is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with haloperidol.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with acemetacin.


The risk or severity of adverse effects can be increased when cabergoline is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Nabilone is combined with fluoxetine.


The risk or severity of adverse effects can be increased when lorazepam is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when cabergoline is combined with rizatriptan.


The risk or severity of adverse effects can be increased when cabergoline is combined with naratriptan.


The risk or severity of adverse effects can be increased when cabergoline is combined with isoniazid.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Olopatadine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Melatonin.


The risk or severity of adverse effects can be increased when Olsalazine is combined with haloperidol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Isoconazole is combined with fluvastatin.


The risk or severity of adverse effects can be increased when pancuronium is combined with Vecuronium.


The risk or severity of adverse effects can be increased when buspirone is combined with butorphanol.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when mesoridazine is combined with promethazine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with sertraline.


The risk or severity of adverse effects can be increased when apomorphine is combined with benazepril.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with GLYCEROL PHENYLBUTYRATE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when HEROIN is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Trospium is combined with methscopolamine.


The risk or severity of adverse effects can be increased when docetaxel is combined with plicamycin.


The risk or severity of adverse effects can be increased when Talniflumate is combined with antipyrine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with flunarizine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with losartan.


The risk or severity of adverse effects can be increased when triamterene is combined with nisoldipine.


The risk or severity of adverse effects can be increased when clonidine is combined with terazosin.


The risk or severity of adverse effects can be increased when Olmesartan is combined with doxazosin.


The risk or severity of adverse effects can be increased when prilocaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when thiamylal is combined with duloxetine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when bromazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when thiamylal is combined with fluoxetine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when formestane is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Halazepam is combined with sertraline.


The risk or severity of adverse effects can be increased when zaleplon is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when temazepam is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when flunarizine is combined with Retigabine.


The risk or severity of adverse effects can be increased when oxycodone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when flumethasone is combined with decamethonium.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when difluprednate is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with prazosin.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when prilocaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when prilocaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when Naftifine is combined with nifedipine.


The risk or severity of adverse effects can be increased when nilvadipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when ketamine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when resveratrol is combined with Mometasone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when protriptyline is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when dibucaine is combined with topiramate.


The risk or severity of adverse effects can be increased when hydromorphone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when metaproterenol is combined with clenbuterol.


The risk or severity of adverse effects can be increased when bepridil is combined with propofol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when chlormezanone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when baclofen is combined with phenytoin.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with phenytoin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with duloxetine.